Ginkgo Bioworks Holdings (DNA) Gains from Investment Securities (2020 - 2025)
Historic Gains from Investment Securities for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q1 2025 value amounting to $207000.0.
- Ginkgo Bioworks Holdings' Gains from Investment Securities rose 12202.13% to $207000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $207000.0, marking a year-over-year increase of 10264.84%. This contributed to the annual value of -$5.7 million for FY2024, which is 1031.35% down from last year.
- According to the latest figures from Q1 2025, Ginkgo Bioworks Holdings' Gains from Investment Securities is $207000.0, which was up 12202.13% from -$1.5 million recorded in Q3 2024.
- Over the past 5 years, Ginkgo Bioworks Holdings' Gains from Investment Securities peaked at $18.6 million during Q1 2022, and registered a low of -$107.5 million during Q4 2021.
- In the last 5 years, Ginkgo Bioworks Holdings' Gains from Investment Securities had a median value of -$940000.0 in 2024 and averaged -$6.0 million.
- Per our database at Business Quant, Ginkgo Bioworks Holdings' Gains from Investment Securities crashed by 99709.18% in 2021 and then soared by 12202.13% in 2025.
- Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Gains from Investment Securities stood at -$107.5 million in 2021, then soared by 73.15% to -$28.9 million in 2022, then surged by 92.67% to -$2.1 million in 2023, then grew by 27.75% to -$1.5 million in 2024, then surged by 113.55% to $207000.0 in 2025.
- Its Gains from Investment Securities was $207000.0 in Q1 2025, compared to -$1.5 million in Q3 2024 and -$3.2 million in Q2 2024.